Search Results 801-810 of 18075 for STD

  1. Low-Dose Tamoxifen Citrate in Reducing Breast Cancer Risk in Radiation-Induced Cancer Survivors - Mayo Clinic

    About this study. Estrogen can cause the growth of breast cancer cells. Hormone therapy using tamoxifen citrate may fight breast cancer by blocking the use ...

  2. Mayo Clinic

    3X challenge extended through 1/15! · About Mayo Clinic · Medical Professionals · Businesses · Students · Researchers · International Patients · Charitable Care & ...

  3. Publications - Martha F. Hartz, M.D. - Mayo Clinic

    Aghazadeh N, Chattha AJ, Hartz MF, Davis DMR. Autoimmune progesterone dermatitis in the adolescent population. Pediatr Dermatol. 2021 Mar; 38(2):380-384. Epub ...

  4. Drugs and Supplements that Start with P - Mayo Clinic

    Drugs and Supplements · P P & S Also known as. Salicylic acid (topical route) · Pa. Pacaps. Also known as. Butalbital, acetaminophen, and caffeine (oral route).

  5. Publications - Randa Tao, M.D. - Mayo Clinic

    Keltner SJ, Hallemeier C, Wang K, Tao R, Shah S, Heimbach J, Kharofa JR. Neoadjuvant Therapy Regimens for Hilar Cholangiocarcinoma Before Liver Transplant. Am J ...

  6. A Study of Adults 65 Years or Older to Establish Normal Lymphocyte Subsets and Immunoglobulin Levels - Mayo Clinic

    The purpose of this study is to evaluate baseline lymphocyte subsets and immunoglobulin levels in adults ≥ 65 years without clinical suspicion of ...

  7. Adnexal tumors and masses - Doctors and departments - Mayo Clinic

    ... Sexually transmitted disease, Ectopic pregnancy, Ovarian cyst, Uterine polyps, Primary ovarian insufficiency, Menopause, Chronic pelvic pain, Vaginal ...

  8. A Study to Examine the Paternity Rates of Men with a History of Testicular Torsion - Mayo Clinic

    Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and ...

  9. Polio - Symptoms and causes - Mayo Clinic

    Learn more about this contagious viral illness that affects the nervous system. Severe disease can lead to paralysis, trouble breathing and sometimes death.

  10. A Study to Assess the Safety and Tolerability of Atezolizumab in Combination With Other Immune-Modulating Therapies in Participants With Locally Advanced or Metastatic Solid Tumors - Mayo Clinic

    The atezolizumab plus obinutuzumab) (Arm E) will enroll participants with recurrent and/or metastatic (R/M) head and neck squamous cell carcinoma (HNSCC).